Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Aposcience AG has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 examiners and 2 art units, indicating separate examination contexts.
DUNN, LINDSAY MICHELLE is the busiest examiner, with 1 pending matter. Counsel should maintain distinct response strategies while coordinating any common technical positions across the two matters.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (67%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DUNN, LINDSAY MICHELLE | 1 | 85.7% | +0.0% |
| WRIGHT, ERIC BRANDON | 1 | 50.0% | +100.0% |
| MOSS, NATALIE M | 1 | 30.7% | +16.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17782801 | COMPOSITION FOR TREATING OR PREVENTING AN ALLERGY OR ALLERGIC REACTION | MOSS, NATALIE M | 23d |
| 18714034 | COMPOSITION FOR TREATING OR PREVENTING VASCULITIS AND DISEASES ASSOCIATED WITH VASCULITIS | DUNN, LINDSAY MICHELLE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17782801 | COMPOSITION FOR TREATING OR PREVENTING AN ALLERGY OR ALLERGIC REACTION | MOSS, NATALIE M | 23d |
| 18554515 | TREATMENT OF SKIN SCARS | WRIGHT, ERIC BRANDON | — |
| Art Unit | Apps |
|---|---|
| 1644 | 1 |
| 1632 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18714034 | COMPOSITION FOR TREATING OR PREVENTING VASCULITIS AND DISEASES ASSOCIATED WITH VASCULITIS | DUNN, LINDSAY MICHELLE | 1644 | §103§112Other | Non-Final OA | — | Pending | May 28, 2024 |
| 18554515 | TREATMENT OF SKIN SCARS | WRIGHT, ERIC BRANDON | 1632 | Other | Final Rejection | — | Pending | Oct 09, 2023 |
| 17782801 | COMPOSITION FOR TREATING OR PREVENTING AN ALLERGY OR ALLERGIC REACTION | MOSS, NATALIE M | 1653 | §102§103§112 | Final Rejection | 23d | Pending | Jun 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAposcience AG has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.
Lindsay Michelle Dunn has the most, with 1 of Aposcience AG's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.